Abstract
Peri-Transplant Alemtuzumab Levels Predict Risk of Secondary Graft Failure and Inversely Impact CXCL9 Levels after RIC HCT (A Correlative Biology Study to BMT-CTN 1204 RICHI)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have